LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 86.03 | 21.74 | 5903 | 6155 | 0.9590 | 0.9898 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 86.03 | 21.74 | 625 | 6155 | 0.1015 | 0.5103 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 86.03 | 21.74 | 5427 | 6155 | 0.8817 | 0.9693 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 88.00 | 21.74 | 6073 | 6081 | 0.9986 | 0.9997 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 88.00 | 21.74 | 6090 | 6081 | 1.0014 | 1.0003 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 88.00 | 21.74 | 562 | 6081 | 0.0924 | 0.4920 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 88.00 | 21.74 | 5581 | 6081 | 0.9177 | 0.9790 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 89.97 | 21.74 | 6320 | 6084 | 1.0387 | 1.0094 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 89.97 | 21.74 | 6336 | 6084 | 1.0413 | 1.0100 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 89.97 | 21.74 | 587 | 6084 | 0.0965 | 0.5000 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 89.97 | 21.74 | 5818 | 6084 | 0.9562 | 0.9890 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 91.94 | 21.74 | 6544 | 6121 | 1.0690 | 1.0165 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 91.94 | 21.74 | 6559 | 6121 | 1.0714 | 1.0170 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 91.94 | 21.74 | 645 | 6121 | 0.1054 | 0.5168 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 91.94 | 21.74 | 6080 | 6121 | 0.9932 | 0.9983 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 93.92 | 21.74 | 6764 | 6070 | 1.1143 | 1.0268 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 93.92 | 21.74 | 6776 | 6070 | 1.1163 | 1.0273 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 93.92 | 21.74 | 696 | 6070 | 0.1147 | 0.5320 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 93.92 | 21.74 | 6280 | 6070 | 1.0346 | 1.0084 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 2.24 | 21.74 | 597 | 183 | 3.2521 | 1.9338 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 2.24 | 21.74 | 2 | 183 | 0.0109 | -0.5394 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 2.24 | 21.74 | 696 | 183 | 3.7914 | 2.0837 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 4.24 | 21.74 | 773 | 317 | 2.4325 | 1.5165 | MN20160310_N01 | H06 |